Manulife (Manufacturers Life Insurance)’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-369
Closed -$1K 4513
2017
Q2
$1K Sell
369
-17
-4% -$51 ﹤0.01% 4342
2017
Q1
$1K Hold
386
﹤0.01% 4178
2016
Q4
$1K Hold
386
﹤0.01% 4326
2016
Q3
$1K Buy
+386
New +$1.46K ﹤0.01% 4271
2016
Q2
Sell
-7,265
Closed -$41K 4504
2016
Q1
$41K Sell
7,265
-53,203
-88% -$691K ﹤0.01% 3345
2015
Q4
$1.04K Buy
60,468
+11,282
+23% +$269K ﹤0.01% 1612
2015
Q3
$1.04K Buy
49,186
+42,504
+636% +$1.46M ﹤0.01% 1579
2015
Q2
$331 Sell
6,682
-1,468
-18% -$87.8K ﹤0.01% 2431
2015
Q1
$638 Buy
8,150
+296
+4% +$18.4K ﹤0.01% 1951
2014
Q4
$476 Sell
7,854
-188
-2% -$9.44K ﹤0.01% 2016
2014
Q3
$342 Buy
8,042
+689
+9% +$37K ﹤0.01% 2245
2014
Q2
$455K Sell
7,353
-255
-3% -$14.8K ﹤0.01% 2098
2014
Q1
$494 Buy
7,608
+350
+5% +$23.7K ﹤0.01% 2080
2013
Q4
$409 Sell
7,258
-230
-3% -$12.9K ﹤0.01% 2192
2013
Q3
$459 Sell
7,488
-293
-4% -$19.8K ﹤0.01% 2045
2013
Q2
$455K Buy
+7,781
New +$479K ﹤0.01% 1959

Other funds holding OREX

Manulife (Manufacturers Life Insurance)'s OREX Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2017, closing a stake of 369 shares — an estimated $1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in OREX in Q2 2013 and held it in 16 quarters. The position peaked at $455K in Q2 2014. 42 funds tracked by Wall St. Rank hold OREX as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 369 Orexigen Therapeutics, Inc. shares in Q3 2017, an estimated $1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Orexigen Therapeutics, Inc. position peaked at $455K in Q2 2014.
  • 42 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.